Outlook Therapeutics Inc. (OTLK)
Market Closed
16 Oct, 08:00 PM
$
0. 49
-0.01
-2.4%
$
121.72M Market Cap
- P/E Ratio
- Div Yield
3.11M Volume
-0.23 Eps
$ 0.5
Previous Close 
Want to track OTLK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call Transcript
Outlook Therapeutics, Inc. (NASDAQ:OTLK ) Q2 2024 Earnings Conference Call May 16, 2024 8:30 AM ET Company Participants Jenene Thomas - IR, JTC Team, LLC Russell Trenary - President & CEO Lawrence Kenyon - Chief Financial Officer Conference Call Participants Julian Harrison - BTIG Eddie Hickman - Guggenheim Securities Douglas Tsao - HC Wainwright Timothy Chiang - Capital One Kemp Dolliver - Brookline Capital Markets Ed Woo - Ascendiant Capital Markets Daniil Gataulin - Chardan Operator Hello, and welcome to the Outlook Therapeutics Inaugural Quarterly Update Conference Call and Webcast. As a brief reminder all participants are currently in a listen-only mode.
Seekingalpha | 2 years ago
2026 © Marketlog. All Rights Reserved.
